Xilio Therapeutics(us:XLO)
1.28
+36.46%
Updated on 2024-12-22
Open:1.06
Close:1.28
High:1.28
Low:0.8364
Pre Close:0.9380
Volume:6.83M
Amount:7.52M
Turnover:15.54%
Shares:43.96M
MarketCap:56.27M
About Xilio Therapeutics Company
Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.
Company Name: Xilio Therapeutics
Company Address: 828 Winter Street,Suite 300
Employees: 73
Fiscar Year: 12-31
IPO Date: 2021-10-22
Website: http://www.xiliotx.com
CIK: 1840233
View all SEC Filings
About
Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.
Address:828 Winter Street,Suite 300
Website:http://www.xiliotx.com
Market Movers